Sustained improvement in general health-related quality of life and work productivity in patients with moderate to severe psoriasis treated with guselkumab: 5-year data from clinical trial VOYAGE 2

被引：0

作者：

Reich, Kristian ^{[1
]}

Gordon, Kenneth B. ^{[2
]}

Foley, Peter ^{[3
]}

Lomaga, Mark ^{[4
]}

Han, Chenglong ^{[5
]}

Miller, Megan ^{[6
]}

You, Yin ^{[6
]}

Radtke, Marc Alexander ^{[7
]}

Wu, Jashin J. ^{[8
]}

Armstrong, April W. ^{[9
]}

机构：

[1] Univ Med Ctr Hamburg Eppendorf, Inst Hlth Serv Res Dermatol & Nursing, Translat Res Inflammatory Skin Dis, Hamburg, Germany

[2] Med Coll Wisconsin, Milwaukee, WI 53226 USA

[3] Univ Melbourne, St Vincents Hosp Melbourne & Prob Med Res, Skin Hlth Inst, Melbourne, Vic, Australia

[4] DermEdge Res, Mississauga, ON, Canada

[5] Janssen Global Serv LLC, Raritan, NJ USA

[6] Janssen Res & Dev LLC, Raritan, NJ USA

[7] Univ Klinikum Hamburg Eppendorf, Hamburg, Germany

[8] Dermatol Res & Educ Fdn, Irvine, CA USA

[9] Univ Southern Calif, Los Angeles, CA 90007 USA

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2021年 / 85卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

28096

引用

页码：AB174 / AB174

页数：1

共 50 条

[31] Patient-reported symptoms and signs in patients with moderate-severe plaque psoriasis treated with guselkumab or adalimumab: Results from VOYAGE 1, a phase III clinical trial
Blauvelt, Andrew
Papp, Kim
Griffiths, Christopher E. M.
Han, Chenglong
Randazzo, Bruce
Wasfi, Yasmine
Li, Shu
Kimball, Alexa B.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB191 - AB191
[32] Improvements in health-related quality of life measured by SF-36 and EQ-5D in patients with moderate to severe plaque psoriasis treated with brodalumab
Paul, Carle
Barker, Jonathan
Klekotka, Paul
Milmont, Cassandra
Viswanathan, Hema
Nirula, Ajay
Brazier, John
Harrison, David
Mutebi, Alex
Kricorian, Gregory
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB256 - AB256
[33] Improvement in Patient-Reported Outcomes (Dermatology Life Quality Index and the Psoriasis Symptoms and Signs Diary) with Guselkumab in Moderate-to-Severe Plaque Psoriasis: Results from the Phase III VOYAGE 1 and VOYAGE 2 Studies
Armstrong, April W.
Reich, Kristian
Foley, Peter
Han, Chenglong
Song, Michael
Shen, Yaung-Kaung
You, Yin
Papp, Kim A.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2019, 20 (01) : 155 - 164
[34] Improvement in Patient-Reported Outcomes (Dermatology Life Quality Index and the Psoriasis Symptoms and Signs Diary) with Guselkumab in Moderate-to-Severe Plaque Psoriasis: Results from the Phase III VOYAGE 1 and VOYAGE 2 Studies
April W. Armstrong
Kristian Reich
Peter Foley
Chenglong Han
Michael Song
Yaung-Kaung Shen
Yin You
Kim A. Papp
American Journal of Clinical Dermatology, 2019, 20 : 155 - 164
[35] Sustained virologic response in patients with cirrhosis from chronic hepatitis C leads to sustained and long-term improvement of health-related quality of life, fatigue, and work productivity
Younossi, Zobair
Stepanova, Maria
Racilla, Andrei
Jacobson, Ira
Muir, Andrew
Zeuzem, Stefan
Lawitz, Eric
Pol, Stanislas
Gaggar, Anuj
Myers, Robert
Younossi, Issah
Nader, Fatema
JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E54 - E55
[36] Improvement of health-related quality of life and work productivity in chronic hepatitis C patients with early and advanced fibrosis treated with ledipasvir and sofosbuvir
Younossi, Zobair M.
Stepanova, Maria
Afdhal, Nezam
Kowdley, Kris V.
Zeuzem, Stefan
Henry, Linda
Hunt, Sharon L.
Marcellin, Patrick
JOURNAL OF HEPATOLOGY, 2015, 63 (02) : 337 - 345
[37] Improvement in physical but not mental Health-Related Quality of Life observed in Axial Spondyloarthritis patients over a 5-year period.
Rohde, Gudrun
Berg, Kari Hansen
Proven, Anne
Haugeberg, Glenn
QUALITY OF LIFE RESEARCH, 2017, 26 (01) : 81 - 81
[38] Quality of life improvement as measured by EQ-5D is consistent with clinical response in moderate to severe plaque psoriasis patients treated with adalimumab
Melilli, LE
Shikiar, R
Thompson, C
VALUE IN HEALTH, 2005, 8 (06) : A147 - A147
[39] Health-related quality of life and work productivity associated with HiSCR and NRS30 response among patients with moderate to severe hidradenitis suppurativa
Kimball, Alexandra
Yang, Min
Song, Yan
Valdecantos, Wendell
Ganguli, Arijit
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB151 - AB151
[40] EFFECT OF ADALIMUMAB ON PHYSICAL FUNCTION, HEALTH-RELATED QUALITY OF LIFE, AND WORK PRODUCTIVITY IN PATIENTS WITH PERIPHERAL SPONDYLOARTHRITIS: RESULTS FROM THE ABILITY-2 CLINICAL TRIAL
Mease, P. J.
Rao, S.
Betts, K. A.
Lu, M.
Fan, L.
Pangan, A. L.
van der Heijde, D.
Cifaldi, M. A.
ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 86 - 86

← 1 2 3 4 5 →